Carroll v. Novartis Pharmaceuticals Corporation et al
| Dennis P Carroll |
| TAKEDA DEVELOPMENT CENTER AMERICAS INC., NOVARTIS CONSUMER HEALTH INC., NOVARTIS VACCINES AND DIAGNOSTICS INC., ASTRAZENECA LP, Takeda Pharmaceuticals Usa, Inc, Novartis Institues for Biomedical Research, Inc., NOVARTIS PHARMACEUTICALS CORPORATION, Merck Sharp & Dohme Corporation, TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER INC., GlaxoSmithKline Consumer Healthcare Holdings (US) IP LLC, ASTRAZENECA PHARMACEUTICALS LP, TAKEDA PHARMACEUTICALS AMERICA INC., Procter & Gamble Company The and Procter & Gamble Manufacturing Company, The |
| PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) |
| 2:2021cv00674 |
| January 13, 2021 |
| US District Court for the District of New Jersey |
| Claire C Cecchi |
| Mark Falk |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 28, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 NOTICE of Appearance by KERRY CARSON GREEN on behalf of Procter & Gamble Manufacturing Company, The, Procter & Gamble Company The (GREEN, KERRY) |
| Filing 10 Clerk's Notice to Counsel. (gh, ) |
| Filing 9 Certified Copy of Transfer Order and docket received, Case transferred in from District of Illinois Northern; Case Number 1:20-cv-07665. Original file certified copy of transfer order and docket sheet received. |
| Filing 8 TRANSFERRED to the District of New Jersey the electronic record. (gcy, ) |
| Member Case Transferred on 1/13/21, from the Northern District of Illinois 1:20-cv-07665 for MDL 2789 PROTON-PUMP INHIBITOR PRODUCTS LIABILITY LITIGATION (No. II) (gh, ) |
| Judge Claire C. Cecchi and Chief Mag. Judge Mark Falk added. (gh, ) |
| For all Case Management Orders #click here (gh, ) |
| Filing 6 MAILED Notice of Removal to counsel of record. (lma, ) |
| Filing 7 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to District of New Jersey.(gcy, ) Modified on 1/13/2021 (gcy, ). |
| ***Civil Case Terminated Pursuant to MDL 2789 Conditional Transfer Order filed 1/6/21. (gcy, ) |
| Filing 5 MINUTE entry before the Honorable Andrea R. Wood: Telephonic initial status conference set for 1/21/2021 at 10:00 AM. To ensure public access to court proceedings, members of the public and media may call in to listen to telephonic hearings. The call-in number is (888) 557-8511 and the access code is 3547847. Counsel of record will receive an email 30 minutes prior to the start of the telephonic hearing with instructions to join the call. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court-issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. The parties are directed to meet and conduct a planning conference pursuant to Federal Rule of Civil Procedure 26(f). At least seven days before the initial status hearing, the parties shall file a joint written status report, not to exceed five pages in length. The initial status report shall provide the information described on the Court's website at www.ilnd.uscourts.gov under District Judges, Judge Andrea R. Wood, Initial Status Conference. Mailed notice (dal, ) |
| CASE ASSIGNED to the Honorable Andrea R. Wood. Designated as Magistrate Judge the Honorable Sheila M. Finnegan. Case assignment: Random assignment. (jg, ) |
| Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by GlaxoSmithKline Consumer Healthcare Holdings (US) IP LLC, Novartis Consumer Health, Inc. (Carwinski, Timothy) |
| Filing 3 ATTORNEY Appearance for Defendants GlaxoSmithKline Consumer Healthcare Holdings (US) IP LLC, Novartis Consumer Health, Inc. by Timothy Robert Carwinski (Carwinski, Timothy) |
| Filing 2 CIVIL Cover Sheet (Carwinski, Timothy) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, case number (2019 L 005962) filed by GlaxoSmithKline Consumer Healthcare Holdings (US) IP LLC, Novartis Consumer Health, Inc. Filing fee $ 402, receipt number 0752-17771352. (Attachments: #1 Exhibit A1, #2 Exhibit A2, #3 Exhibit B, #4 Exhibit C)(Carwinski, Timothy) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
